ASCO 2013 Report – Sorafenib shows efficacy in advanced differentiated thyroid cancer
by Bruce Sylvester – over 30,000 clinicians and researchers attended the American Society of Clinical Oncology 2013 annual meeting in Chicago on May 31-June 4. Among the most… read more.